SGLT2 Inhibitors to Slow Chronic Kidney Disease Progression: A Review
Rebecca Maxson, Jessica Starr, Jeanna Sewell, Claretha Lyas
Topics & Concepts
EmpagliflozinMedicineCanagliflozinDapagliflozinKidney diseaseDiabetes mellitusInternal medicineRandomized controlled trialClinical trialNephropathyRenal functionIntensive care medicineEndocrinologyType 2 diabetesDiabetes Treatment and ManagementChronic Kidney Disease and DiabetesPancreatic function and diabetes